Olema Oncology, a clinical-stage biopharmaceutical company focused on breast cancer therapies, announced its participation in three upcoming investor conferences: TD Cowen Oncology Innovation Summit on May 26, Jefferies Global Healthcare Conference on June 3, and Goldman Sachs Global Healthcare Conference on June 9. These events will feature fireside chats and provide updates on Olema's pipeline, including its lead drug palazestrant in Phase 3 trials and OP-3136 in Phase 1. Live webcasts will be available on Olema's investor relations website. This participation highlights Olema's ongoing efforts to engage investors and share progress on its targeted cancer treatments.
Enhabit Home Health & Hospice is set to report its quarterly earnings on May 20, 2026, with analysts expecting earnings per share of $0.12 and revenue around $266.66 million. The company recently underwent leadership changes, appointing Dale Clift as...
Kerrisdale Capital has taken a short position on Everspin Technologies, arguing the recent surge in its stock price is driven by misplaced enthusiasm around AI-related memory demand. Everspin's MRAM technology targets niche industrial markets rather ...
TheBestReputation launched AIOverview.com, a free tool that scans five major AI search engines—ChatGPT, Claude, Google AI Overview, Gemini, and Perplexity—to show businesses how their brand appears in AI-generated search results. This is crucial as o...
Vuzix Corporation is exhibiting its advanced AI-powered smart glasses and waveguide solutions at SOF Week 2026 in Tampa, Florida. These products are designed for defense use, offering mission-ready optical performance in challenging environments, inc...
MoneyFlare has introduced an AI-powered trading bot designed to automate trading in both cryptocurrency and stock markets. This tool aims to simplify automated trading by handling market monitoring, data analysis, strategy execution, and trade manage...
